You are here
Clinical Trials: Eye Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Retinitis Pigmentosa
Intervention: Biological: Retinal pigment epitheliums transplantation
Sponsors: Qi Zhou; Beijing Tongren Hospital
Recruiting
Intervention: Biological: Retinal pigment epitheliums transplantation
Sponsors: Qi Zhou; Beijing Tongren Hospital
Recruiting
Conditions: Dry Eye; Kerato Conjunctivitis Sicca; Aqueous Tear Deficiency
Intervention: Drug: Adipose tissue-derived mesenchymal stem cells
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Intervention: Drug: Adipose tissue-derived mesenchymal stem cells
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Conditions: Alzheimer Disease; Alzheimer Dementia; Vascular Dementia; Lewy Body Disease; Lewy Body Dementia With Behavioral Disturbance (Disorder); Dementia, Mixed; Parkinson-Dementia Syndrome; Chronic Traumatic Encephalopathy; Huntington's Dementia; Wernicke Korsakoff Syndrome; Traumatic Brain Injury; Dementia, Multi-Infarct; Autism; Autism Spectrum Disorder; Autistic Behavior; Autistic Disorder, Current or Active State
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Condition: Macular Holes
Intervention: Biological: exosomes derived from mesenchymal stem cells (MSC-Exo)
Sponsor: Tianjin Medical University
Recruiting
Intervention: Biological: exosomes derived from mesenchymal stem cells (MSC-Exo)
Sponsor: Tianjin Medical University
Recruiting
Conditions: Ocular Discomfort; Ocular Inflammation; Dry Eye; Contact Lens Complication; Keratoconjunctivitis Sicca
Intervention: Drug: Lifitegrast
Sponsors: University of Alabama at Birmingham; Shire
Not yet recruiting
Intervention: Drug: Lifitegrast
Sponsors: University of Alabama at Birmingham; Shire
Not yet recruiting
Conditions: Dry Eye Syndromes; Dry Eye; Ocular Inflammation; Ocular Surface Disease; Ocular Discomfort; Blepharitis
Intervention: Other: Corneal Epithelial Stem Cell Transplant
Sponsor: Sloan W. Rush, MD
Recruiting
Intervention: Other: Corneal Epithelial Stem Cell Transplant
Sponsor: Sloan W. Rush, MD
Recruiting
Conditions: Corneal Haze After Photo Therapeutic/Refractive Keratectomy; Corneal Haze After Collagen Cross Linking
Interventions: Biological: stem cells after standard surgical therapy; Other: Vehicle
Sponsor: L.V. Prasad Eye Institute
Recruiting
Interventions: Biological: stem cells after standard surgical therapy; Other: Vehicle
Sponsor: L.V. Prasad Eye Institute
Recruiting
Condition: Non Arteritic Ischemic Optic Neuropathy
Intervention: Procedure: intravitreal injection of MSV
Sponsors: Instituto Universitario de Oftalmobiología Aplicada; University of Valladolid
Not yet recruiting - verified June 2017
Intervention: Procedure: intravitreal injection of MSV
Sponsors: Instituto Universitario de Oftalmobiología Aplicada; University of Valladolid
Not yet recruiting - verified June 2017
Condition: Age-Related Macular Degeneration
Interventions: Drug: ASP7317; Other: Placebo; Drug: Prograf®; Drug: mycophenolate mofetil (MMF)
Sponsor: Astellas Institute for Regenerative Medicine
Not yet recruiting - verified June 2017
Interventions: Drug: ASP7317; Other: Placebo; Drug: Prograf®; Drug: mycophenolate mofetil (MMF)
Sponsor: Astellas Institute for Regenerative Medicine
Not yet recruiting - verified June 2017
Condition: Retinitis Pigmentosa
Intervention: Biological: human retinal progenitor cells
Sponsor: jCyte, Inc
Recruiting - verified March 2017
Intervention: Biological: human retinal progenitor cells
Sponsor: jCyte, Inc
Recruiting - verified March 2017
